88 related articles for article (PubMed ID: 6433802)
21. [Home chemotherapy by concomitant UFT + Leucovorin (po.) in postoperative colorectal cancer patients assessed with Dukes D and curability C colorectal cancer].
Sakuyama T; Yokoyama M; Ogawa M; Takao Y; Sato K; Kawahara H; Anazawa S; Yamazaki Y; Hirai K
Gan To Kagaku Ryoho; 2004 May; 31(5):771-5. PubMed ID: 15170991
[TBL] [Abstract][Full Text] [Related]
22. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
[TBL] [Abstract][Full Text] [Related]
23. Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
Hayakawa M; Morise K; Chin K; Sugihara M; Morooka Y; Maeda H; Hattori T; Saito H
Jpn J Clin Oncol; 1994 Oct; 24(5):282-8. PubMed ID: 7967107
[TBL] [Abstract][Full Text] [Related]
24. [A case of advanced gastric cancer with multiple liver metastasis successfully treated with combination chemotherapy using UFT, CDDP and etoposide].
Ono T; Komatsu M; Hoshino T; Ishii T; Fujii K; Ohshima S; Mikami K; Masamune O; Fukuda T
Gan To Kagaku Ryoho; 1996 Oct; 23(12):1709-12. PubMed ID: 8886050
[TBL] [Abstract][Full Text] [Related]
25. Phase II trial of UFT activity in pretreated breast cancer patients.
Daniels M; Díaz-Rubio E; Guillem V; Montero JM; García-Conde J; Estapé J; Martín M; Herranz C; Ordoñez A; Galán A
Jpn J Clin Oncol; 1993 Dec; 23(6):363-5. PubMed ID: 8283790
[TBL] [Abstract][Full Text] [Related]
26. [Clinical trial of UFT against disseminated breast cancer].
Itoh S; Konishi Y; Harauchi D; Shinoto M
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2381-5. PubMed ID: 6437344
[TBL] [Abstract][Full Text] [Related]
27. [A case of laryngeal cancer treated for over 2 years with UFT and CBDCA alone].
Iwasaki K; Oida I; Usami A; Hashimoto Y; Yamada M; Ozawa T
Gan To Kagaku Ryoho; 1999 Feb; 26(3):369-72. PubMed ID: 10065103
[TBL] [Abstract][Full Text] [Related]
28. Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancer.
Gemma A; Kudoh S; Yoshimura A; Ono Y; Takenaka K; Hayashihara K; Hino M; Shibuya M; Niitani H
Anticancer Res; 1995; 15(6B):2691-5. PubMed ID: 8669849
[TBL] [Abstract][Full Text] [Related]
29. [Clinical effects of oral administration of UFT on gynecological malignant tumors].
Sagara Y; Akiyama J; Takeda Y
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Aug; 36(8):1287-90. PubMed ID: 6439802
[No Abstract] [Full Text] [Related]
30. [Efficacy of uracil/tegafur (UFT) plus oral Leucovorin (LV) therapy for colorectal cancer in elderly patients].
Mizushima T; Mizuno H; Ito T; Hoki M; Souma Y; Iwamoto T; Ozawa H; Kanou T; Nakamori Y; Iwase K
Gan To Kagaku Ryoho; 2006 Jul; 33(7):941-4. PubMed ID: 16835484
[TBL] [Abstract][Full Text] [Related]
31. [Preoperative chemotherapy for advanced colorectal carcinomas--comparison of histological effect between UFT + leucovorin tablet and UFT alone].
Maruyama M; Kudo T; Kuwabara H; Yoshida T; Sugano N; Ebuchi M
Gan To Kagaku Ryoho; 1998 Apr; 25(5):691-6. PubMed ID: 9571966
[TBL] [Abstract][Full Text] [Related]
32. Phase II study of uracil-tegafur plus cisplatin in patients with previously untreated advanced non-small cell lung cancer.
Takayama K; Kawasaki M; Ninomiya K; Motohiro A; Fujita M; Watanabe K; Kajiki A; Iwami F; Miyazaki N; Izumi M; Hara N; Nakanishi Y;
Respirology; 2008 Jan; 13(1):103-7. PubMed ID: 18197918
[TBL] [Abstract][Full Text] [Related]
33. UFT: biochemical modulation for 5-fluorouracil (5-FU).
Taguchi T
Chin Med J (Engl); 1997 Apr; 110(4):294-6. PubMed ID: 9594232
[No Abstract] [Full Text] [Related]
34. [Clinical effect of UFT on urogenital tumors].
Masuda F; Arai Y; Tashiro K; Machida T
Hinyokika Kiyo; 1984 Jan; 30(1):81-5. PubMed ID: 6428200
[TBL] [Abstract][Full Text] [Related]
35. [Retrospective analysis of tegafur/uracil (UFT) plus oral leucovorin (LV) regimen in patients with advanced colorectal cancer].
Sato Y; Inaba Y; Yamaura H; Shimamoto H; Nishiofuku H; Oyama T; Kanemitsu Y; Sawaki A; Arai Y; Muro K
Gan To Kagaku Ryoho; 2006 Jul; 33(7):887-90. PubMed ID: 16835473
[TBL] [Abstract][Full Text] [Related]
36. [Clinical study of ambulatory patient cancer chemotherapy for advanced colorectal cancer].
Toyokawa A; Tsujimura T; Hamabe Y; Sato S; Mukubou H; Wakahara T; Kaji M; Tsukamoto T; Wakita K; Onishi N; Ishida T; Watanabe A; Fujiwara H; Mukai H
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2087-90. PubMed ID: 16352933
[TBL] [Abstract][Full Text] [Related]
37. [Concentration of 5-FU level in the tissue and blood of the patients with breast cancer by preoperative administration of UFT].
Suemasu K; Nomoto C; Higashi Y
Gan To Kagaku Ryoho; 1982 Apr; 9(4):667-71. PubMed ID: 6820904
[TBL] [Abstract][Full Text] [Related]
38. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
Shirao K; Hoff PM; Ohtsu A; Loehrer PJ; Hyodo I; Wadler S; Wadleigh RG; O'Dwyer PJ; Muro K; Yamada Y; Boku N; Nagashima F; Abbruzzese JL
J Clin Oncol; 2004 Sep; 22(17):3466-74. PubMed ID: 15277535
[TBL] [Abstract][Full Text] [Related]
40. Contrasting effects of extended low dose versus standard dose shorter course UFT chemotherapy on microscopic versus macroscopic established tumors: implications for optimal postoperative adjuvant chemotherapy.
Uchida J; Okabe H; Nakano K; Fujioka A; Saito H; Sugimoto Y; Oka T; Fukushima M
Oncol Rep; 2007 Aug; 18(2):313-9. PubMed ID: 17611650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
